SARS-CoV-2


Sherlock Bio gets Emergency Use Authorization for CRISPR-based Diagnostics of SARS-CoV-2

It was about a year ago that I highlighted here some neat graphene technology out of Cardea Biosciences, and in that context I mentioned CRISPR-based diagnostics. (If interested, you can find the post here.) The FDA recently approved under Emergency Use Authorization (EUA) Sherlock BioSciences’ SARS-CoV-2 Rapid diagnostic (FDA EUA […]

Screencap of http://sherlock.bio announcement of EUA approval